Update on diagnostic and therapeutic challenges of central hypothyroidism among childhood cancer survivors.
Casiraghi Alice, Cattoni Alessandro, Persani Luca·Journal of endocrinological investigation
CONTEXT: Following the exposure to toxic therapeutic agents employed in the treatment of malignancies, endocrine complications can affect up to 40-60% of childhood cancer survivors (CCS), with central hypothyroidism (CeH) being a relevant adverse event observed in this population. Given the long-standing uptrend in the…